After Hours
$
5.09
Change
-0.02 -0.39%
Volume
Volume 3,633
Jan 31, 2023, 7:32 p.m.
Quotes are delayed by 20 min
Today's close
$ 4.85
$ 5.11
Change
+0.26 +5.36%
Day low
Day high
$4.84
$5.39

52 week low
52 week high
$3.02
$21.90

Market cap
$98.10M
Average volume
120,319
P/E ratio
N/A
Rev. per Employee
$189,000
EPS
-16.39
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on SYRS
-
Syros Pharmaceuticals stock price target cut to $10 from $14 at Alliance Global
- Tomi Kilgore
-
Syros Pharmaceuticals stock price target cut to $8 from $10 at Wedbush
- Tomi Kilgore
-
Syros Pharmaceuticals downgraded to neutral from outperform at Wedbush
- Tomi Kilgore
-
Syros Pharmaceuticals started at outperform with $18 stock price target at Wedbush Securities
- Tomi Kilgore
-
Syros Pharmaceuticals sets IPO price expectations
- Tomi Kilgore
-
Syros Pharmaceuticalsto offer 4 mln shares in its IPO
- Tomi Kilgore
-
Syros Pharmaceuticals expects IPO price of between $14 and $16 a share
- Tomi Kilgore
Analyst Ratings
-
5 Keys To Understanding Syros Pharma's ASH Presentation
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For August 10, 2017
- Benzinga.com
Other News on SYRS
-
10-Q: SYROS PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Syros Pharmaceuticals Q3 2022 Earnings Preview
- Seeking Alpha
-
Notable earnings before Monday's open
- Seeking Alpha
-
Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders
- Seeking Alpha
-
AVCT, MSC and VTAQ among mid-day movers
- Seeking Alpha
-
10-Q: SYROS PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
- Loading more headlines...
Press Releases on SYRS
-
Syros Announces Clinical Updates and 2023 Strategic Priorities
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Syros to Participate at Piper Sandler 34th Annual Healthcare Conference
- BusinessWire - BZX
-
Syros to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Syros and Tyme Technologies Announce Stockholder Approval of Merger
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com